Legal Opinion
BALES v. ASTRAZENECA PHARMACEUTICALS LP
District Court, D. New Jersey
Decided June 17, 2022No. 2:17-cv-06124Unknown
1Opinion
UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY IN RE: PROTON-PUMP INHIBITOR PRODUCTS LIABILITY LITIGATION 2:17-MD-2789 (CCC) (LDW) (MDL 2789) This Document Relates to: Judge Claire C. Cecchi Bales v. AstraZeneca Pharmaceuticals LP, 2:17-cv-06124 REPORT AND RECOMMENDATION OF SPECIAL MASTER ELLEN REISMAN REGARDING PLAINTIFF BALES’S MOTION TO DISQUALIFY DR. ANDREA LEONARD-SEGAL Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Development Center Americas, Inc. f/k/a Takeda Global Research & Development Center, Inc., and Takeda Pharmaceuticals U.S.A., Inc.…
2Cases cited3 opinions
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- Crandon v. United StatesSupreme Court of the United States · 1990
- Aybar v. JohnsonDistrict Court, D. New Jersey · 2018